An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Gritstone bio to Participate in Upcoming Investor and Scientific Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Gritstone bio, Inc. (Nasdaq: GRTS) announces participation in upcoming investor and scientific conferences to showcase its innovative personalized cancer vaccines. The events will feature presentations and panels discussing clinical trial results and advancements in cancer vaccine technology.
Positive
None.
Negative
None.
EMERYVILLE, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today announced that management will be participating in the following investor and scientific conferences. Select events (marked by *) will be webcasted live and webcast details will be available on the ‘Events’ page of Gritstone bio’s website: https://ir.gritstonebio.com/investors/events. Archived replays will be accessible for 30 days following each event.
23rd Annual Needham Virtual Healthcare Conference (Presentation*) Date and Time: Tuesday, April 9, 2024 at 11:00am ET Location: Virtual
Canaccord Genuity Horizons in Oncology Virtual Conference (Panel) Panel Title: Cancer Vaccines – Building on Recent Learnings Date and Time: Monday, April 15, 2024 at 11:00am ET Location: Virtual
Cambridge Healthtech Institute’s Immuno-Oncology Summit Europe (Presentation) Presentation Title: Clinical Trial Results with a Personalised Neoantigen Vaccine in a Cold Tumour—Can We Bring the Heat? Date and Time: Wednesday, April 24, 2024 at 9:05am BST Location: London, UK
7th International Neoantigen Summit (Presentation) Panel Title: Clinical Trial Data with a Personalised Neoantigen Cancer Vaccine in Metastatic Colorectal Cancer Panel Date and Time: Tuesday, April 30, 2024 at 12:30pm CEST Location: Amsterdam, Netherlands
PEGS BOSTON (Panel) Panel Title: Personalized Cancer Vaccines - Where are They Going Now? Date and Time: Monday, May 13, 2024 at 9:00am ET Location: Boston, MA
Citizens JMP Life Sciences Conference (Fireside Chat*) Date and Time: Tuesday, May 14, 2024 at 10:30am ET Location: New York, NY
About Gritstone bio Gritstone bio, Inc. (Nasdaq: GRTS) is a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines. We leverage our innovative vectors and payloads to train multiple arms of the immune system to attack critical disease targets. Independently and with our collaborators, we are advancing a portfolio of product candidates to treat and prevent viral diseases and solid tumors in pursuit of improving patient outcomes and eliminating disease. www.gritstonebio.com
Gritstone Contacts Investors: George E. MacDougall Gritstone bio, Inc. ir@gritstone.com
Gritstone bio will be presenting at the 23rd Annual Needham Virtual Healthcare Conference on Tuesday, April 9, 2024, at 11:00am ET.
Investors can find webcast details for the events on the 'Events' page of Gritstone bio's website: https://ir.gritstonebio.com/investors/events.
The panel at the Canaccord Genuity Horizons in Oncology Virtual Conference will focus on Cancer Vaccines - Building on Recent Learnings on Monday, April 15, 2024, at 11:00am ET.
Gritstone bio will present at the Cambridge Healthtech Institute’s Immuno-Oncology Summit Europe in London, UK, on Wednesday, April 24, 2024, at 9:05am BST.
The panel at the 7th International Neoantigen Summit will discuss Clinical Trial Data with a Personalised Neoantigen Cancer Vaccine in Metastatic Colorectal Cancer on Tuesday, April 30, 2024, at 12:30pm CEST.
Gritstone bio will participate in the PEGS BOSTON conference in Boston, MA, on Monday, May 13, 2024, at 9:00am ET.
Gritstone bio will engage in a Fireside Chat at the Citizens JMP Life Sciences Conference in New York, NY, on Tuesday, May 14, 2024, at 10:30am ET.
gritstone oncology is a cancer immunotherapy company developing next-generation personalized cancer therapeutics. gritstone brings together distinguished scientific founders, an experienced and diverse management team, a seasoned and successful board of directors, and very deep financial backing to tackle fundamental challenges at the intersection of cancer biology, immunology, and immunotherapy design. the company’s initial goal is to identify and deploy therapeutic neo-antigens from individual patients’ tumors to develop novel treatments for lung cancer. gritstone oncology is headquartered in the san francisco bay area with certain key functions located in cambridge, ma. gritstone oncology launched in october 2015 with a series a financing of $102 million.
